Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users (vol 32, pg 216, 2015)

Laliberte Francois; Cloutier Michel; Crivera Concetta; Nelson Winnie W.; Olson William H.; Schein Jeffrey; Vanderpoel Julie; Germain Guillaume; Lefebvre Patrick

首页> 外文期刊>Advances in therapy. >Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users (vol 32, pg 216, 2015)

【24h】

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users (vol 32, pg 216, 2015)

机译：利伐沙班和华法林对非瓣膜性房颤患者医疗保健费用的影响：利伐沙班使用者和匹配的华法林使用者的观察（第32卷，第216页，2015年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Advances in therapy.》 |2015年第4期|共1页
作者
Laliberte Francois; Cloutier Michel; Crivera Concetta; Nelson Winnie W.; Olson William H.; Schein Jeffrey; Vanderpoel Julie; Germain Guillaume; Lefebvre Patrick;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users (vol 32, pg 216, 2015) [J] . Laliberte Francois, Cloutier Michel, Crivera Concetta, Advances in therapy. . 2015,第4期

机译：利伐沙班和华法林对非瓣膜性房颤患者医疗保健费用的影响：利伐沙班使用者和匹配的华法林使用者的观察（第32卷，第216页，2015年）
2. Effects of Rivaroxaban versus Warfarin on Hospitalization Days and other Health Care Resource Utilization in Patients with Nonvalvular Atrial Fibrillation: an Observational Study from a Cohort of Matched Users (vol 37, pg 554, 2015) [J] . Laliberte Francois, Cloutier Michel, Crivera Concetta, Clinical therapeutics . 2015,第8期

机译：利伐沙班与华法林对非瓣膜性心房颤动患者住院天数和其他医疗资源利用的影响：来自一组匹配用户的观察性研究（第37卷，第554页，2015年）
3. Effects of Rivaroxaban versus Warfarin on Hospitalization Days and other Health Care Resource Utilization in Patients with Nonvalvular Atrial Fibrillation: an Observational Study from a Cohort of Matched Users (vol 37, pg 554, 2015) [J] . Laliberte Francois, Cloutier Michel, Crivera Concetta, Clinical therapeutics . 2015,第8期

机译：raivaroxaban对varfarin对非衰弱性颤动患者住院日和其他医疗资源利用的影响：匹配用户队列的观察研究（Vol 37，PG 554,2015）
4. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
5. Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users [O] . François Laliberté, Michel Cloutier, Concetta Crivera, -1

机译：利伐沙班和华法林对非瓣膜性房颤患者医疗保健费用的影响：利伐沙班使用者和配套的华法林使用者的观察
6. Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users [O] . François Laliberté, Michel Cloutier, Concetta Crivera, 2015

机译：利伐沙班和华法林对非瓣膜性房颤患者医疗保健费用的影响：利伐沙班使用者和配套的华法林使用者的观察

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users (vol 32, pg 216, 2015)

著录项

相似文献

相关主题

期刊订阅